Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MorphoSys Q4 EPS $0.33 Beats $0.09 Estimate, Sales $63.51M Miss $67.89M Estimate

Author: Benzinga Newsdesk | March 13, 2024 04:16pm
MorphoSys (NASDAQ:MOR) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.09 by 266.67 percent. This is a 85.53 percent decrease over earnings of $2.28 per share from the same period last year. The company reported quarterly sales of $63.51 million which missed the analyst consensus estimate of $67.89 million by 6.46 percent. This is a 23.75 percent decrease over sales of $83.29 million the same period last year.

Posted In: MOR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist